These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Naming and counting disorders (conditions) included in newborn screening panels. Sweetman L; Millington DS; Therrell BL; Hannon WH; Popovich B; Watson MS; Mann MY; Lloyd-Puryear MA; van Dyck PC Pediatrics; 2006 May; 117(5 Pt 2):S308-14. PubMed ID: 16735257 [TBL] [Abstract][Full Text] [Related]
26. Newborn screening for genetic disorders. Fernhoff PM Pediatr Clin North Am; 2009 Jun; 56(3):505-13, Table of Contents. PubMed ID: 19501689 [TBL] [Abstract][Full Text] [Related]
27. Expanded newborn screening: implications for genomic medicine. McCabe LL; McCabe ER Annu Rev Med; 2008; 59():163-75. PubMed ID: 18186702 [TBL] [Abstract][Full Text] [Related]
28. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated? Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947 [TBL] [Abstract][Full Text] [Related]
29. Prenatal and newborn screening for hemoglobinopathies. Hoppe CC Int J Lab Hematol; 2013 Jun; 35(3):297-305. PubMed ID: 23590658 [TBL] [Abstract][Full Text] [Related]
30. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Garg U; Dasouki M Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365 [TBL] [Abstract][Full Text] [Related]
31. Review of the spectrum of genetic diseases in Bahrain. al-Arrayed SS East Mediterr Health J; 1999 Nov; 5(6):1114-20. PubMed ID: 11924098 [TBL] [Abstract][Full Text] [Related]
33. Population screening: report of a workshop. Scriver CR Prog Clin Biol Res; 1985; 163B():89-152. PubMed ID: 2580316 [No Abstract] [Full Text] [Related]
34. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
35. Best practices: antenatal screening for common genetic conditions other than aneuploidy. Ram KT; Klugman SD Curr Opin Obstet Gynecol; 2010 Apr; 22(2):139-45. PubMed ID: 20125016 [TBL] [Abstract][Full Text] [Related]
36. Are we ready for universal genetic screening? Simpson JL Reprod Biomed Online; 2010 Oct; 21(4):437-9. PubMed ID: 20813585 [No Abstract] [Full Text] [Related]
37. Population screening for carrier status: effects of test limitations on precision of carrier prevalence rates. Parker RA; Phillips JA Am J Med Genet; 1994 Feb; 49(3):317-22. PubMed ID: 8209893 [TBL] [Abstract][Full Text] [Related]
38. [Ethical and psychological aspects of screening tests for children]. Dehlholm G; Hansen D Nord Med; 1993; 108(11):297-9. PubMed ID: 8247721 [TBL] [Abstract][Full Text] [Related]
39. A review of newborn screening in the era of tandem mass spectrometry: what's new for the pediatric neurologist? Copeland S Semin Pediatr Neurol; 2008 Sep; 15(3):110-6. PubMed ID: 18708000 [TBL] [Abstract][Full Text] [Related]
40. Integration of new genetic diseases into statewide newborn screening: New England experience. Comeau AM; Larson C; Eaton RB Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):35-41. PubMed ID: 14755432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]